New Delhi, 9/4:Bharat Biotech has announced a price revision of its Covid-19 vaccine Covaxin from Rs 1,200 to Rs 225 per dose for supply in private hospitals.
Serum Institute of India that manufactures Covishield also made a similar announcement, slashing its vaccine’s single dose price from Rs 600 to Rs 225.
The decision comes a day ahead of the commencement of precautionary dose drive in the private sector on Sunday. The union health ministry had stated that all those adults above 18 years of age, who have completed nine months since they were administered the second dose are eligible for the third dose.
While the priority groups like senior citizens, health and front line workers are eligible for a free third dose at the government run facilities like during the first and second dose inoculation, others have to pay for the third dose.
Comments are closed.